Aspen Group Delivers Positive Cash Flow from Operations in Fiscal Q1 2025
Rhea-AI Summary
Aspen Group (ASPU) reported Q1 fiscal 2025 results with revenue of $11.3 million, down 23% year-over-year. The company posted a net loss of $0.3 million or $0.01 per share, improving from a $0.6 million loss in the prior year. Gross margin remained stable at 66%.
Key operational highlights include transitioning from HCM2 to HCM1 financial aid payment method, restructuring debt, and implementing cost reductions projected to save over $1.5 million annually. The company completed its BSN Pre-licensure program teach-out in September 2024 and is now focusing on post-licensure nursing programs, particularly USU's MSN-FNP program with an LTV of $17,820 per enrollment.
Total active student body decreased to 6,622 from 8,591 year-over-year, while new student enrollments were down 19% year-over-year but increased 3% sequentially.
Positive
- Net loss improved to $0.3 million from $0.6 million year-over-year
- Maintained strong gross margin at 66%
- Successfully transitioned from HCM2 to HCM1 financial aid payment method
- Implemented cost reductions expected to save over $1.5 million annually
- Resolved key regulatory challenges including removal of show cause directive
Negative
- Revenue declined 23% to $11.3 million year-over-year
- Total active student body decreased 23% to 6,622 from 8,591
- New student enrollments down 19% year-over-year
- Aspen University revenue decreased 38%
- USU revenue decreased 5%
News Market Reaction 1 Alert
On the day this news was published, ASPU gained 17.51%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
- Reports Revenue of
$11.3 Million in Fiscal Q1 2025 - Further restructured operating expenses and debt to preserve cash and position the company for sustained positive EBITDA
- Successfully resolved outstanding regulatory issues during calendar year 2024
- Completion of teach-out for all AU BSN Pre-licensure students as of September 2024
- Demand for post-licensure nursing degrees remains strong
PHOENIX, Dec. 06, 2024 (GLOBE NEWSWIRE) -- Aspen Group, Inc. (OTC Markets: ASPU) (“AGI”), an education technology holding company, today announced financial results for its first quarter of fiscal year 2025 ended July 31, 2024.
First Quarter Fiscal Year 2025 Summary Results
| Three Months Ended July 31, | |||||||
| $ in millions, except per share data | 2024 | 2023 | |||||
| Revenue | $ | 11.3 | $ | 14.6 | |||
| Gross Profit1 | $ | 7.5 | $ | 9.8 | |||
| Gross Margin (%)1 | 66 | % | 67 | % | |||
| Net Income (Loss) Available to Common Stockholders | $ | (0.3 | ) | $ | (0.6 | ) | |
| Earnings (Loss) per Share Available to Common Stockholders | $ | (0.01 | ) | $ | (0.03 | ) | |
| EBITDA2 | $ | 1.0 | $ | 1.3 | |||
| Adjusted EBITDA2 | $ | 0.4 | $ | 1.9 | |||
_______________________
1 GAAP gross profit calculation includes marketing and promotional costs, instructional costs and services, and amortization expense of
2 Non-GAAP financial measures. See reconciliations of GAAP to non-GAAP financial measures under "Non-GAAP–Financial Measures" starting on page 4.
“Over the past year, AGI has successfully addressed its key regulatory challenges, including the removal of Aspen University’s show cause directive by the Distance Education Accrediting Commission (DEAC) and AU’s transition off the HCM2 financial aid payment method with the Department of Education,” said Michael Mathews, Chairman and CEO of AGI. “Furthermore, we recently took steps to further reduce our operating expenses, and we restructured our debt, positioning the company to achieve positive cash flow and positive EBITDA and Adjusted EBITDA. These measures collectively strengthen our liquidity and position us for sustained financial stability, enabling AGI to reinvest in marketing and drive student enrollment growth by the end of fiscal year 2025.”
Mr. Mathews continued, “Following the completion of AU’s BSN Pre-licensure program teach-out in September 2024, our focus has shifted to positioning the company to expand enrollment in our traditional post-licensure nursing programs, with particular concentration on USU’s MSN-FNP program, now our highest LTV program at
Fiscal Q1 2025 Financial and Operational Results (compared to Fiscal Q1 2024)
Revenue decreased
| Three Months Ended July 31, | |||||||||||||||
| 2024 | $ Change | % Change | 2023 | ||||||||||||
| AU | $ | 4,791,904 | $ | (2,931,021 | ) | (38 | )% | $ | 7,722,925 | ||||||
| USU | 6,536,933 | (380,014 | ) | (5 | )% | 6,916,947 | |||||||||
| Revenue | $ | 11,328,837 | $ | (3,311,035 | ) | (23 | )% | $ | 14,639,872 | ||||||
Aspen University (AU) revenue decreased by
United States University (USU) revenue decreased
GAAP gross profit decreased
AU instructional costs and services represented
The following tables present the Company’s net income (loss) available to common stockholders, both per subsidiary and total:
| Three Months Ended July 31, 2024 | |||||||||||||||
| Consolidated | AGI Corporate | AU | USU | ||||||||||||
| Net (loss) income available to common stockholders | $ | (269,016 | ) | $ | (1,584,916 | ) | $ | (491,022 | ) | $ | 1,806,922 | ||||
| Net loss per share available to common stockholders | $ | (0.01 | ) | ||||||||||||
| Three Months Ended July 31, 2023 | |||||||||||||||
| Consolidated | AGI Corporate | AU | USU | ||||||||||||
| Net (loss) income available to common stockholders | $ | (639,438 | ) | $ | (3,805,601 | ) | $ | 646,376 | $ | 2,519,787 | |||||
| Net loss per share available to common stockholders | $ | (0.03 | ) | ||||||||||||
The following tables present the Company’s Non-GAAP measures, both per subsidiary and total. See reconciliations of GAAP to non-GAAP financial measures under “Non-GAAP–Financial Measures” starting on page 4.
| Three Months Ended July 31, 2024 | ||||||||||||||||
| Consolidated | AGI Corporate | AU | USU | |||||||||||||
| EBITDA | $ | 1,039,102 | $ | (1,018,946 | ) | $ | 112,814 | $ | 1,945,234 | |||||||
| EBITDA Margin | 9 | % | NM | 2 | % | 30 | % | |||||||||
| Adjusted EBITDA | 447,615 | (1,635,054 | ) | (99,794 | ) | 2,182,463 | ||||||||||
| Adjusted EBITDA Margin | 4 | % | NM | (2 | )% | 33 | % | |||||||||
| _______________ NM – Not meaningful | ||||||||||||||||
| Three Months Ended July 31, 2023 | ||||||||||||||||
| Consolidated | AGI Corporate | AU | USU | |||||||||||||
| EBITDA | $ | 1,344,405 | $ | (2,738,712 | ) | $ | 1,427,102 | $ | 2,656,015 | |||||||
| EBITDA Margin | 9 | % | NM | 18 | % | 38 | % | |||||||||
| Adjusted EBITDA | 1,881,854 | (2,691,840 | ) | 1,685,160 | 2,888,534 | |||||||||||
| Adjusted EBITDA Margin | 13 | % | NM | 22 | % | 42 | % | |||||||||
Liquidity
The Fiscal Q1 2025 ending unrestricted cash balance of approximately
Cost reductions associated with the four restructuring plans and other corporate cost reductions were implemented to ensure that the company will have sufficient cash to meet its working capital needs for the next 12 months.
Operating Metrics
New Student Enrollments
On a Company-wide basis, new student enrollments were down
New student enrollments for the past five quarters are shown below:
| Q1'24 | Q2'24 | Q3'24 | Q4'24 | Q1'25 | |||||
| AU | 626 | 808 | 473 | 427 | 413 | ||||
| USU | 389 | 548 | 325 | 370 | 410 | ||||
| Total | 1,015 | 1,356 | 798 | 797 | 823 | ||||
Total Active Student Body
Total active student body for the past five quarters is shown below:
| Q1'24 | Q2'24 | Q3'24 | Q4'24 | Q1'25 | |||||
| AU | 6,001 | 5,679 | 5,146 | 4,559 | 4,145 | ||||
| USU | 2,590 | 2,733 | 2,503 | 2,489 | 2,477 | ||||
| Total | 8,591 | 8,412 | 7,649 | 7,048 | 6,622 | ||||
Nursing Students
Nursing student body for the past five quarters are shown below:
| Q1'24 | Q2'24 | Q3'24 | Q4'24 | Q1'25 | |||||
| AU | 4,766 | 4,470 | 4,032 | 3,526 | 3,198 | ||||
| USU | 2,349 | 2,432 | 2,270 | 2,262 | 2,254 | ||||
| Total | 7,115 | 6,902 | 6,302 | 5,788 | 5,452 | ||||
Non-GAAP – Financial Measures
This press release includes both financial measures in accordance with Generally Accepted Accounting Principles, or GAAP, as well as non-GAAP financial measures. Generally, a non-GAAP financial measure is a numerical measure of a company’s performance, financial position or cash flows that either excludes or includes amounts that are not normally included or excluded in the most directly comparable measure calculated and presented in accordance with GAAP. Non-GAAP financial measures should be viewed as supplemental to and should not be considered as alternatives to net income (loss), operating income (loss), and cash flow from operating activities, liquidity or any other financial measures. They may not be indicative of the historical operating results of AGI nor are they intended to be predictive of potential future results. Investors should not consider non-GAAP financial measures in isolation or as substitutes for performance measures calculated in accordance with GAAP.
Our management uses and relies on EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Adjusted Gross Profit, which are non-GAAP financial measures. We believe that management, analysts and shareholders benefit from referring to the following non-GAAP financial measures to evaluate and assess our core operating results from period-to-period after removing the impact of items that affect comparability. Our management recognizes that the non-GAAP financial measures have inherent limitations because of the excluded items described below.
We have included a reconciliation of our non-GAAP financial measures to the most comparable financial measures calculated in accordance with GAAP. We believe that providing the non-GAAP financial measures, together with the reconciliation to GAAP, helps investors make comparisons between AGI and other companies. In making any comparisons to other companies, investors need to be aware that companies use different non-GAAP measures to evaluate their financial performance. Investors should pay close attention to the specific definition being used and to the reconciliation between such measure and the corresponding GAAP measure provided by each company.
AGI defines Adjusted EBITDA as EBITDA excluding: (1) bad debt expense; (2) stock-based compensation; (3) severance; and (4) non-recurring charges. The following table presents a reconciliation of net loss to EBITDA and Adjusted EBITDA and of net income (loss) margin to Adjusted EBITDA Margin:
| Three Months Ended July 31, | |||||||
| 2024 | 2023 | ||||||
| Net loss | $ | (127,864 | ) | $ | (639,438 | ) | |
| Interest expense, net | 347,170 | 936,460 | |||||
| Taxes | (208 | ) | 84,171 | ||||
| Depreciation and amortization | 820,004 | 963,212 | |||||
| EBITDA | 1,039,102 | 1,344,405 | |||||
| Bad debt expense | 450,000 | 450,000 | |||||
| Stock-based compensation | 210,091 | 87,449 | |||||
| Severance | 50,707 | — | |||||
| Non-recurring charges - Other | (1,302,285 | ) | — | ||||
| Adjusted EBITDA | $ | 447,615 | $ | 1,881,854 | |||
| Net loss Margin | (1 | )% | (4 | )% | |||
| Adjusted EBITDA Margin 1 | 4 | % | 13 | % | |||
_______________________
1 Adjusted EBITDA Margin is defined as Adjusted EBITDA divided by revenue. Adjusted EBITDA margin has certain limitations in that it does not take into account the impact on our consolidated statement of operations of certain expenses.
The following tables present a reconciliation of Net income (loss) to EBITDA and Adjusted EBITDA and of Net loss margin to Adjusted EBITDA margin by subsidiary:
| Three Months Ended July 31, 2024 | |||||||||||||||||||
| Consolidated | AGI Corporate | AU | USU | ||||||||||||||||
| Net income (loss) | $ | (127,864 | ) | $ | (1,443,764 | ) | $ | (491,022 | ) | $ | 1,806,922 | ||||||||
| Interest expense, net | 347,170 | 347,170 | — | — | |||||||||||||||
| Taxes | (208 | ) | 92 | — | (300 | ) | |||||||||||||
| Depreciation and amortization | 820,004 | 77,556 | 603,836 | 138,612 | |||||||||||||||
| EBITDA | 1,039,102 | (1,018,946 | ) | 112,814 | 1,945,234 | ||||||||||||||
| Bad debt expense | 450,000 | — | 225,000 | 225,000 | |||||||||||||||
| Stock-based compensation | 210,091 | 201,754 | 6,865 | 1,472 | |||||||||||||||
| Severance | 50,707 | 3,125 | 36,825 | 10,757 | |||||||||||||||
| Non-recurring charges - Other | (1,302,285 | ) | (820,987 | ) | (481,298 | ) | — | ||||||||||||
| Adjusted EBITDA | $ | 447,615 | $ | (1,635,054 | ) | $ | (99,794 | ) | $ | 2,182,463 | |||||||||
| Net income (loss) Margin | (1 | )% | NM | (10 | )% | 28 | % | ||||||||||||
| Adjusted EBITDA Margin | 4 | % | NM | (2 | )% | 33 | % | ||||||||||||
_______________________
NM - Not meaningful
| Three Months Ended July 31, 2023 | |||||||||||||||
| Consolidated | AGI Corporate | AU | USU | ||||||||||||
| Net income (loss) | $ | (639,438 | ) | $ | (3,805,601 | ) | $ | 646,376 | $ | 2,519,787 | |||||
| Interest expense, net | 936,460 | 936,481 | (6 | ) | (15 | ) | |||||||||
| Taxes | 84,171 | 54,766 | 19,425 | 9,980 | |||||||||||
| Depreciation and amortization | 963,212 | 75,642 | 761,307 | 126,263 | |||||||||||
| EBITDA | 1,344,405 | (2,738,712 | ) | 1,427,102 | 2,656,015 | ||||||||||
| Bad debt expense | 450,000 | — | 225,000 | 225,000 | |||||||||||
| Stock-based compensation | 87,449 | 46,872 | 33,058 | 7,519 | |||||||||||
| Adjusted EBITDA | $ | 1,881,854 | $ | (2,691,840 | ) | $ | 1,685,160 | $ | 2,888,534 | ||||||
| Net income (loss) Margin | (4 | )% | NM | 8 | % | 36 | % | ||||||||
| Adjusted EBITDA Margin | 13 | % | NM | 22 | % | 42 | % | ||||||||
Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 including the impact of our operating and debt restructurings and expected positive operating cash flow and positive EBITDA and future growth. The words “believe,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. The results anticipated by any or all of these forward-looking statements might not occur. Important factors, uncertainties and risks that may cause actual results to differ materially from these forward-looking statements include, without limitation, the impact from our last restructuring plan. our ability to sublease our remaining leases other than our executive offices and necessary space used by AU and USU, the continued high demand for nurses for our new programs and in general, student attrition, national and local economic factors including the labor market shortages, competition from other online universities including the competitive impact from the trend of major non-profit universities using online education , the effectiveness of our future marketing and the impact of any Federal Reserve interest rate changes on the economy. We undertake no obligation to publicly update or revise any forward-looking statements, whether as the result of new information, future events or otherwise.
About Aspen Group, Inc.
Aspen Group, Inc. is an education technology holding company that leverages its infrastructure and expertise to allow its two universities, Aspen University and United States University, to deliver on the vision of making college affordable again.
Investor Relations Contact
Kim Rogers
Managing Director
Hayden IR
385-831-7337
Kim@HaydenIR.com
GAAP Financial Statements
| ASPEN GROUP, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS | |||||||
| July 31, 2024 | April 30, 2024 | ||||||
| (Unaudited) | |||||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 1,308,843 | $ | 1,531,425 | |||
| Restricted cash | 1,088,002 | 1,088,002 | |||||
| Accounts receivable, net of allowance of | 18,738,129 | 19,686,527 | |||||
| Prepaid expenses | 508,752 | 502,751 | |||||
| Other current assets | 1,417,092 | 1,785,621 | |||||
| Total current assets | 23,060,818 | 24,594,326 | |||||
| Property and equipment: | |||||||
| Computer equipment and hardware | 888,566 | 886,152 | |||||
| Furniture and fixtures | 1,974,271 | 1,974,271 | |||||
| Leasehold improvements | 6,553,314 | 6,553,314 | |||||
| Instructional equipment | 529,299 | 529,299 | |||||
| Software | 9,072,488 | 8,784,996 | |||||
| 19,017,938 | 18,728,032 | ||||||
| Less: accumulated depreciation and amortization | (10,331,034 | ) | (9,542,520 | ) | |||
| Total property and equipment, net | 8,686,904 | 9,185,512 | |||||
| Goodwill | 5,011,432 | 5,011,432 | |||||
| Intangible assets, net | 7,900,000 | 7,900,000 | |||||
| Courseware and accreditation, net | 353,065 | 363,975 | |||||
| Long-term contractual accounts receivable | 17,550,272 | 17,533,030 | |||||
| Operating lease right-of-use assets, net | 9,598,303 | 10,639,838 | |||||
| Deposits and other assets | 699,470 | 718,888 | |||||
| Total assets | $ | 72,860,264 | $ | 75,947,001 | |||
(Continued)
| ASPEN GROUP, INC. AND SUBSIDIARIES CONSOLIDATED BALANCE SHEETS (CONTINUED) | |||||||
| July 31, 2024 | April 30, 2024 | ||||||
| (Unaudited) | |||||||
| Liabilities and Stockholders’ Equity | |||||||
| Liabilities: | |||||||
| Current liabilities: | |||||||
| Accounts payable | $ | 2,115,294 | $ | 2,311,360 | |||
| Accrued expenses | 3,099,740 | 2,880,478 | |||||
| Advances on tuition | 2,300,046 | 2,030,501 | |||||
| Deferred tuition | 3,344,645 | 4,881,546 | |||||
| Due to students | 2,419,963 | 2,558,492 | |||||
| Current portion of long-term debt | 2,915,863 | 2,284,264 | |||||
| Operating lease obligations, current portion | 2,264,213 | 2,608,534 | |||||
| Other current liabilities | 488,991 | 86,495 | |||||
| Total current liabilities | 18,948,755 | 19,641,670 | |||||
| Long-term debt, net | 5,994,907 | 6,776,506 | |||||
| Operating lease obligations, less current portion | 14,259,290 | 14,999,687 | |||||
| Put warrants liabilities | 1,143,606 | 1,964,593 | |||||
| Other long-term liabilities | 287,930 | 287,930 | |||||
| Total liabilities | 40,634,488 | 43,670,386 | |||||
| Commitments and contingencies | |||||||
| Stockholders’ equity: | |||||||
| Preferred stock, | 10 | 10 | |||||
| Common stock, | |||||||
| 25,701,603 issued and 25,701,603 outstanding at April 30, 2024 | 25,932 | 25,702 | |||||
| Additional paid-in capital | 121,997,843 | 121,921,048 | |||||
| Accumulated deficit | (89,798,009 | ) | (89,670,145 | ) | |||
| Total stockholders’ equity | 32,225,776 | 32,276,615 | |||||
| Total liabilities and stockholders’ equity | $ | 72,860,264 | $ | 75,947,001 | |||
| ASPEN GROUP, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) | |||||||
| Three Months Ended July 31, | |||||||
| 2024 | 2023 | ||||||
| (Unaudited) | (Unaudited) | ||||||
| Revenue | $ | 11,328,837 | $ | 14,639,872 | |||
| Operating expenses: | |||||||
| Cost of revenue (exclusive of depreciation and amortization shown separately below) | 3,347,225 | 4,392,855 | |||||
| General and administrative | 7,327,334 | 8,470,878 | |||||
| Bad debt expense | 450,000 | 450,000 | |||||
| Depreciation and amortization | 820,004 | 963,212 | |||||
| Total operating expenses | 11,944,563 | 14,276,945 | |||||
| Operating (loss) income | (615,726 | ) | 362,927 | ||||
| Other income (expense): | |||||||
| Interest expense | (347,170 | ) | (936,481 | ) | |||
| Change in fair value of put warrant liability | 820,987 | — | |||||
| Other income, net | 13,837 | 18,287 | |||||
| Total other income (expense), net | 487,654 | (918,194 | ) | ||||
| Loss before income taxes | (128,072 | ) | (555,267 | ) | |||
| Income tax (benefit) expense | (208 | ) | 84,171 | ||||
| Net loss | (127,864 | ) | (639,438 | ) | |||
| Dividends attributable to preferred stock | (141,152 | ) | — | ||||
| Net loss available to common stockholders | $ | (269,016 | ) | $ | (639,438 | ) | |
| Net loss per share - basic and diluted available to common stockholders | $ | (0.01 | ) | $ | (0.03 | ) | |
| Weighted average number of common stock outstanding - basic and diluted | 25,929,218 | 25,567,351 | |||||
| ASPEN GROUP, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) | |||||||
| Three Months Ended July 31, | |||||||
| 2024 | 2023 | ||||||
| (Unaudited) | (Unaudited) | ||||||
| Cash flows from operating activities: | |||||||
| Net loss | $ | (127,864 | ) | $ | (639,438 | ) | |
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||||
| Bad debt expense | 450,000 | 450,000 | |||||
| Depreciation and amortization | 820,004 | 963,212 | |||||
| Stock-based compensation | 151,341 | 87,449 | |||||
| Change in fair value of put warrant liability | (820,987 | ) | — | ||||
| Amortization of warrant-based cost | 7,000 | 7,000 | |||||
| Amortization of debt issuance costs | — | 73,174 | |||||
| Amortization of debt discounts | — | 77,208 | |||||
| Non-cash lease benefit | (124,499 | ) | (196,720 | ) | |||
| Changes in operating assets and liabilities: | |||||||
| Accounts receivable | 481,156 | (2,915,225 | ) | ||||
| Prepaid expenses | (6,001 | ) | (34,123 | ) | |||
| Other current assets | 368,529 | (3,210,237 | ) | ||||
| Deposits and other assets | 19,418 | (571,014 | ) | ||||
| Accounts payable | (196,066 | ) | 180,041 | ||||
| Accrued expenses | 219,262 | 214,859 | |||||
| Due to students | (138,529 | ) | 186,030 | ||||
| Advances on tuition and deferred tuition | (1,267,356 | ) | 812,637 | ||||
| Other current liabilities | 402,496 | (88,317 | ) | ||||
| Net cash provided by (used in) operating activities | 237,904 | (4,603,464 | ) | ||||
| Cash flows from investing activities: | |||||||
| Purchases of courseware and accreditation | (20,580 | ) | (28,020 | ) | |||
| Purchases of property and equipment | (289,906 | ) | (291,632 | ) | |||
| Net cash used in investing activities | (310,486 | ) | (319,652 | ) | |||
| Cash flows from financing activities: | |||||||
| Repayment of portion of | (150,000 | ) | — | ||||
| Proceeds from | — | 10,451,080 | |||||
| Repayment of 2018 Credit Facility | — | (5,000,000 | ) | ||||
| Payments of debt issuance costs | — | (195,661 | ) | ||||
| Net cash (used in) provided by financing activities | $ | (150,000 | ) | $ | 5,255,419 | ||
(Continued)
| ASPEN GROUP, INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED) (Unaudited) | |||||||
| Three Months Ended July 31, | |||||||
| 2024 | 2023 | ||||||
| (Unaudited) | (Unaudited) | ||||||
| Net (decrease) increase in cash, cash equivalents and restricted cash | $ | (222,582 | ) | $ | 332,303 | ||
| Cash, cash equivalents and restricted cash at beginning of period | 2,619,427 | 5,724,467 | |||||
| Cash, cash equivalents and restricted cash at end of period | $ | 2,396,845 | $ | 6,056,770 | |||
| Supplemental disclosure of cash flow information: | |||||||
| Cash paid for interest | $ | 345,413 | $ | 671,031 | |||
| Cash (refunded) paid for income taxes | $ | (208 | ) | $ | 59,172 | ||
| Supplemental disclosure of non-cash investing and financing activities: | |||||||
| Accrued dividends | $ | 141,152 | $ | — | |||
| Relative fair value of warrants issued as part of the | $ | — | $ | 154,000 | |||
The following table provides a reconciliation of cash and cash equivalents and restricted cash reported within the accompanying consolidated balance sheet to the total amounts shown in the accompanying unaudited consolidated statements of cash flows:
| July 31, | |||||||
| 2024 | 2023 | ||||||
| (Unaudited) | (Unaudited) | ||||||
| Cash and cash equivalents | $ | 1,308,843 | $ | 217,370 | |||
| Restricted cash | 1,088,002 | 5,839,400 | |||||
| Total cash, cash equivalents and restricted cash | $ | 2,396,845 | $ | 6,056,770 | |||